ChondroFiller for Focal Defects or Knee OsteoarthritisPatients with focal knee cartilage defects treated with ChondroFiller, an injectable collagen scaffold that recruits the body's own progenitor cells, improve by a mean of 30 points on validated knee-function scales — exceeding clinically meaningful improvement thresholds.Patients with focal knee cartilage defects treated with ChondroFiller, an injectable collagen scaffold that recruits the body's own progenitor cells, improve by a mean of 30 points on validated knee-function scales — exceeding clinically meaningful improvement thresholds.
OATS or OCA for osteochondral knee repairDefect size is the primary determinant in osteochondral knee repair: lesions under 2–4 cm² are treated with OATS (autograft plugs), larger defects with OCA (fresh donor tissue), a distinction reflecting the limits of safe tissue harvest from the patient's own knee.Defect size is the primary determinant in osteochondral knee repair: lesions under 2–4 cm² are treated with OATS (autograft plugs), larger defects with OCA (fresh donor tissue), a distinction reflecting the limits of safe tissue harvest from the patient's own knee.
ChondroFiller injection or knee replacement for younger patientsFor younger patients with diffuse knee wear, ChondroFiller injection places a collagen scaffold via outpatient ultrasound guidance, recruiting progenitor cells to regenerate cartilage tissue, deferring full knee replacement whilst preserving future surgical options.For younger patients with diffuse knee wear, ChondroFiller injection places a collagen scaffold via outpatient ultrasound guidance, recruiting progenitor cells to regenerate cartilage tissue, deferring full knee replacement whilst preserving future surgical options.
ChondroFiller vs hyaluronic acid for knee cartilageChondroFiller and hyaluronic acid solve different cartilage problems entirely: one is a collagen scaffold filling focal defects via cell recruitment; the other replenishes synovial lubricant for diffuse osteoarthritis. Patient imaging determines which is appropriate.ChondroFiller and hyaluronic acid solve different cartilage problems entirely: one is a collagen scaffold filling focal defects via cell recruitment; the other replenishes synovial lubricant for diffuse osteoarthritis. Patient imaging determines which is appropriate.
MACI or knee replacement for younger patientsYoung patients accepting total knee replacement face a 35% lifetime probability of revision surgery; MACI cartilage repair preserves the native knee in nine out of ten well-selected cases over ten years.Young patients accepting total knee replacement face a 35% lifetime probability of revision surgery; MACI cartilage repair preserves the native knee in nine out of ten well-selected cases over ten years.
Unloader knee brace or surgery for cartilage damageUnloader braces open the joint 0.3 mm, modulating cartilage chemistry without rebuilding damage; high tibial osteotomy substantially outperforms bracing for pain relief in younger patients.Unloader braces open the joint 0.3 mm, modulating cartilage chemistry without rebuilding damage; high tibial osteotomy substantially outperforms bracing for pain relief in younger patients.
When ankle sprain needs more than A&EA&E correctly rules out fractures but cannot assess ligament damage; most ankle sprain patients leave with rest-ice advice alone, yet structured physiotherapy reduces 12-month re-injury rates by roughly 40 per cent compared with routine care.A&E correctly rules out fractures but cannot assess ligament damage; most ankle sprain patients leave with rest-ice advice alone, yet structured physiotherapy reduces 12-month re-injury rates by roughly 40 per cent compared with routine care.
ChondroFiller repeat injections and long-term repairChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.ChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.
Knee Cartilage Repair and PreservationArticular cartilage lacks blood vessels, so when damaged it forms fibrocartilage—a mechanically inferior scar tissue that typically deteriorates within two to three years. This biological constraint shapes every treatment option, from temporary symptom relief to procedures attempting true cartilage regeneration.Articular cartilage lacks blood vessels, so when damaged it forms fibrocartilage—a mechanically inferior scar tissue that typically deteriorates within two to three years. This biological constraint shapes every treatment option, from temporary symptom relief to procedures attempting true cartilage regeneration.
Is MACI Knee Surgery Worth It?MACI harvests, cultures, and implants the patient's own cartilage cells across two surgeries weeks apart. It delays knee replacement—7.4% progression over a decade—but requires 12–18 months of recovery and works best for younger patients with focal defects of 3 cm² or more.MACI harvests, cultures, and implants the patient's own cartilage cells across two surgeries weeks apart. It delays knee replacement—7.4% progression over a decade—but requires 12–18 months of recovery and works best for younger patients with focal defects of 3 cm² or more.
Can ChondroFiller delay joint replacement?An injectable collagen scaffold called ChondroFiller recruits the patient's own repair cells to regenerate cartilage in 30–45 minutes. Clinical trials show IKDC score improvements averaging 32.4 points — nearly double the threshold for clinically significant change — when administered in early focal cartilage damage where joint space remains.An injectable collagen scaffold called ChondroFiller recruits the patient's own repair cells to regenerate cartilage in 30–45 minutes. Clinical trials show IKDC score improvements averaging 32.4 points — nearly double the threshold for clinically significant change — when administered in early focal cartilage damage where joint space remains.
When knee pain needs an orthopaedic assessmentMost knee pain settles with rest and physiotherapy; the threshold for orthopaedic assessment is persistent dysfunction despite weeks of conservative care, or acute structural changes—and assessment maps options rather than commits to surgery.Most knee pain settles with rest and physiotherapy; the threshold for orthopaedic assessment is persistent dysfunction despite weeks of conservative care, or acute structural changes—and assessment maps options rather than commits to surgery.